Literature DB >> 8515718

Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone.

K Nahoul1, L Dehennin, M Jondet, M Roger.   

Abstract

Doses of 100 mg of micronized progesterone (P) and of 0.5 mg of micronized estradiol (E2) were administered vaginally and orally, respectively, in the early follicular phase of the menstrual cycle in six premenopausal women. In the second cycle, the same doses were administered in the same subjects, orally for P and vaginally for E2. Serial blood samples were collected and the following steroids were assayed by highly reliable techniques: P, E2, estrone (E1), deoxycorticosterone (DOC), 5 alpha- and 5 beta-pregnanolone and the sulfates of E1, E2, and DOC. Circulating P and E2 levels were higher after vaginal than after oral administration, while those of E1 were similar after either route. Metabolites of P (DOC, DOCS and pregnanolone) were higher after oral administration. Concerning estrogen sulfates, E1S concentrations were similar whichever the route, while those of E2S were lower after oral than after vaginal administration. This study has confirmed that metabolism of ingested P and E2 occurs mainly in the intestine. Moreover, P was predominantly metabolized to 5 alpha-reduced derivatives, whatever the route of administration. In view of the metabolic pathways which are operative and of the peripheral plasma levels which were found, the vaginal route appears to be more adequate than the oral one for hormone replacement therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515718     DOI: 10.1016/0378-5122(93)90064-o

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  19 in total

1.  Has ART Finally Got a Patient-Friendly Progesterone?

Authors:  Gautam N Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2015-10

2.  Comparison of daily vaginal progesterone gel plus weekly intramuscular progesterone with daily intramuscular progesterone for luteal phase support in single, autologous euploid frozen-thawed embryo transfers.

Authors:  Mehmet Resit Asoglu; Cem Celik; Lale Susan Karakis; Necati Findikli; Meral Gultomruk; Mustafa Bahceci
Journal:  J Assist Reprod Genet       Date:  2019-05-18       Impact factor: 3.412

3.  Do serum progesterone levels on day of embryo transfer influence pregnancy outcomes in artificial frozen-thaw cycles?

Authors:  Michelle Volovsky; Cassandra Pakes; Genia Rozen; Alex Polyakov
Journal:  J Assist Reprod Genet       Date:  2020-02-10       Impact factor: 3.412

4.  Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women.

Authors:  Shanna Babalonis; Joshua A Lile; Catherine A Martin; Thomas H Kelly
Journal:  Psychopharmacology (Berl)       Date:  2011-02-25       Impact factor: 4.530

5.  Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women.

Authors:  Shanna Babalonis; Joshua A Lile; Catherine A Martin; Thomas H Kelly
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

6.  Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.

Authors:  Bin Xie; Yang Liu; Yuting Guo; Enbo Zhang; Chenguang Pu; Haibing He; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-02-14       Impact factor: 4.200

7.  Progesterone and estrogen levels are associated with live birth rates following artificial cycle frozen embryo transfers.

Authors:  Ronit Beck-Fruchter; Simon Nothman; Shira Baram; Yoel Geslevich; Amir Weiss
Journal:  J Assist Reprod Genet       Date:  2021-09-18       Impact factor: 3.412

8.  Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.

Authors:  Karen Pazol; Mark E Wilson; Kim Wallen
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.

Authors:  Sarah J Lord; Wendy J Mack; David Van Den Berg; Malcolm C Pike; Sue A Ingles; Christopher A Haiman; Wei Wang; Yuri R Parisky; Howard N Hodis; Giske Ursin
Journal:  Breast Cancer Res       Date:  2005-02-23       Impact factor: 6.466

Review 10.  Progestogens in menopausal hormone therapy.

Authors:  Małgorzata Bińkowska; Jarosław Woroń
Journal:  Prz Menopauzalny       Date:  2015-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.